chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a 72-year-old female with past medical history of hyperlipidemia, coronary artery disease status post CABG x4, anxiety, depression, multiple sclerosis, immunocompromised.    She came to the hospital with a chief complaint of progressive worsening cough and shortness of breath over the last 10 days.  Initially tested positive about 4 days after starting to have symptoms.  Was prescribed azithromycin as an outpatient by her primary care physician.  Her son initially tested positive for COVID-19 after which the patient started having symptoms as well due to exposure.   The patient was having significant worsening of the shortness of breath over the weekend and had a very severe heada 8/11/2021 tested positive This is a 72-year-old female with past medical history of hyperlipidemia, coronary artery disease status post CABG x4, anxiety, depression, multiple sclerosis, immunocompromised.     She came to the hospital with a chief complaint of progressive worsening cough and shortness of breath over the last 10 days.  Initially tested positive about 4 days after starting to have symptoms.  Was prescribed azithromycin as an outpatient by her primary care physician.  Her son initially tested positive for COVID-19 after which the patient started having symptoms as well due to exposure.   The patient was having significant worsening of the shortness of breath over the weekend and had a very severe headache so she decided come to the hospital for further evaluation and treatment.  Patient was also having some cough, chest pain associated with cough, back pain, fevers, chills, nausea, vomiting, loss of taste.  Denies any abdominal pain, burning or painful urination or diarrhea.
2-3 seconds, post vax, pt passed out and had a seizure X 2-3 seconds. After 20 minutes she was alert and talking, immediately. She fet nauseated, vomited X 1, passed out and had a second seizure, lasting 10 seconds.
vaccine_brand Pfizer / BioNTech/product COVID 19 Treatment; vaccine_brand Pfizer / BioNTech/product COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 32-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 07Mar2021 at 10:15 as dose 1, single (Lot number: EN206), in left arm, on 21Mar2021 at 10:15 as dose 2, single (Lot number: ER8733), in left arm and on 29Oct2021 at 14:00 as dose 3 (booster), single (Lot number: 30155BA) at the age of 32 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "eczema" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "vaccine_brand Pfizer / BioNTech/product COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: positive, notes: I am testing extremely strongly positive on antigen tests again, for the third day in a row; positive, notes: I am testing extremely strongly positive on antigen tests again, for the third day in a row; positive, notes: I am testing extremely strongly positive on antigen tests again, for the third day in a row. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: known allergies :No. I'm experiencing a rebound of COVID symptoms that arose 3 days after finishing my Paxlovid series. Symptoms are more mild and cold like than the original COVID infection, which felt like the flu. I am testing extremely strongly positive on antigen tests again, for the third day in a row.
Received vaccination FLUZONE at 1400. Felt very tired at 20:00 and went to sleep. Awoke at 2200 and had temp. 103 with both eyes only swollen shut. No medication taken. Went back to sleep and awoke at 2400 with hallucinations to time and place. Went back to sleep and in AM felt fine with both eyes very red.
Information has been received from a registered nurse concerning a 4 year old female with a history of cleft palate repair on August 2004, who on 08-SEP-2006 was vaccinated subcutaneously in the left arm with a dose of ProQuad (Enders-Edmonston, Jeryl Lynn, Wistar RA 27/3, Oka/Merck upgrade process) (lot # 652679/1137R).  Concomitant vaccination included IPV (unspecified) (lot# 40991).  On 07-JUN-2007 the patient was diagnosed with a case of breakthrough chicken pox after receiving a dose of ProQuad (Enders-Edmonston, Jeryl Lynn, Wistar RA 27/3, Oka/Merck upgrade process).  It was reported that no medical attention was sought.  Approximately 20 to 30 vesicular and papular lesions and few crusted lesions on trunk and legs.  On an unspecified date the patient recovered.  It was also reported that the patient received a first dose of Varivax (Oka/Merck) (MSD) (lot# 645045/0208N) subcutaneously in the left thigh on 22-AUG-2003.  No further information is available.
Patient began to experience tingling in her throat, no swelling or shortness of breath.  At the same time she began to experience a hot sensation in her throat and ears.  Patient was given 25 mg of diphenhydramine along with water.  Patients blood pressure, pulse, and oxygen levels were normal.  Patient was also given ice pack to place on her throat and chest.  Patient rested for about 1 hour and then left on her own, accompanied by her mother.
This spontaneous report was received from a physician concerning an 88 year old patient of unknown gender. The patient's medical history, current conditions, drug reactions/allergies and concomitant therapies were unknown by the reporter. On 10-NOV-2016, the patient was vaccinated with a dose of PNEUMOVAX 23 lot # M037669, expiration date: 09-MAY-2018. (dose was not reported), route of administration reported as injection. On 11-NOV-2016, the patient called the physician's office to inform that she was experiencing "Redness, swelling and warmth at the injection site". The patient sought medical attention by calling at the physician's office. The patient received an unspecified treatment for the events. It was unknown by the reporter if lab diagnostics studies were performed to the patient. At the reporting time, the outcome of the events was unknown. The reporter did not provide the causality between PNEUMOVAX 23 and the events. Additional information has been requested.
got vaccinated, still got shingles / suspected vaccination failure; shingles/ flares up; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional case details were reported as follows: The reporter was patient's wife. The age at vaccination was not reported. The patient got vaccinated but still got shingles, but just a light case flares up every now and then. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required.
really bad aches; Severe flue like symptoms; slept for an entire day and then 10 more hours at night; felt really terrible; their body felt so heavy they could hardly get to the bathroom; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (really bad aches), INFLUENZA LIKE ILLNESS (Severe flue like symptoms), SOMNOLENCE (slept for an entire day and then 10 more hours at night), MALAISE (felt really terrible) and FEELING ABNORMAL (their body felt so heavy they could hardly get to the bathroom) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 013L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (really bad aches), INFLUENZA LIKE ILLNESS (Severe flue like symptoms), SOMNOLENCE (slept for an entire day and then 10 more hours at night), MALAISE (felt really terrible) and FEELING ABNORMAL (their body felt so heavy they could hardly get to the bathroom). At the time of the report, PAIN (really bad aches), INFLUENZA LIKE ILLNESS (Severe flue like symptoms), SOMNOLENCE (slept for an entire day and then 10 more hours at night), MALAISE (felt really terrible) and FEELING ABNORMAL (their body felt so heavy they could hardly get to the bathroom) outcome was unknown.            no treatment and concomitant medication reported   This case was linked to MOD-2021-026582 (Patient Link).
Developed a urinary tract infection, despite the fact that I drink a lot of water and ensure proper hygiene.  Although the symptoms became noticeable on Wednesday 3/30, the clinic's nurse practitioner stated I had blood in my urine and believed the UTI started sooner.  I don't know if "vaccine 1" was responsible, but wanted to report the illiness.
pain in extremity; redness; hot; swelling; itching; somnolence; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in extremity), ERYTHEMA (redness), FEELING HOT (hot), SWELLING (swelling) and PRURITUS (itching) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 29-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in extremity), ERYTHEMA (redness), FEELING HOT (hot), SWELLING (swelling), PRURITUS (itching) and SOMNOLENCE (somnolence). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 30-Mar-2021, PAIN IN EXTREMITY (pain in extremity) had resolved. At the time of the report, ERYTHEMA (redness), FEELING HOT (hot), SWELLING (swelling), PRURITUS (itching) and SOMNOLENCE (somnolence) had not resolved. Not Provided          Concomitant medications details were not reported by the reporter.
redness at injection site; injection site pain/ arm tendernes; underdose; Inadvertent exposure to vaccine; exposure via skin contact; This case was reported by a consumer via call center representative and described the occurrence of erythema of extremities in a 74-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 15th May 2019, the patient received Shingrix. On 15th May 2019, unknown after receiving Shingrix, the patient experienced accidental underdose, inadvertent exposure to vaccine and exposure via skin contact. On 16th May 2019, 1 days after receiving Shingrix, the patient experienced erythema of extremities and pain in arm. On 17th May 2019, the outcome of the erythema of extremities and pain in arm were recovered/resolved. On an unknown date, the outcome of the accidental underdose, inadvertent exposure to vaccine and exposure via skin contact were unknown.   It was unknown if the reporter considered the erythema of extremities and pain in arm to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix vaccine in her left deltoid. On 15th May 2019, the pharmacist was going to get a bandaid to cover the injection site, she noticed that some of the injection was coming out of the back of her arm and dripping off her elbow, which led to accidental underdoes, inadvertent exposure to vaccine and exposure via skin contact. The pharmacist stated that perhaps she had the syringe filled to high. The patient asked if she received enough of a dose or if she was okay to get second dose in 2-6 months.  The pharmacist did follow up with someone from their company and her pharmacist was told the injection would still be effective.   The patient did not feel the fluid going into her arm during the injection but that her husband said that he felt it going into his arm when he got it.  The patient  reported that her arm was red and painful, and tender to the touch starting the next night and it lasted for a day. The patient reported that  when she got the flu shot that the injection site usually gets red and big right away.
bloody nose/HBP; bloody nose/HBP; This is a spontaneous report from a contactable consumer (patient). A 79-year-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), intramuscularly, administered in the left arm on 13Mar2021 at 11:30 (Batch/Lot Number: EN9262, Expiration date: unknown) as the 2nd dose, single for COVID-19 immunization. The patient received the 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscularly, administered in the left arm on 19Feb2021 at 10:30 AM at the age of 79 years old (Batch/Lot number: EN6198) for COVID-19 immunization. The vaccine facility type was reported as the urgent care center. Relevant medical history included some digestive issues on an unspecified date in the past, skin cancer (CA) in 1985/1993, and basal cell on an unspecified date with ongoing basal cell on face biopsy from 14Feb2021. There were no concomitant medications. The patient was very healthy and never had any high blood pressure (HBP) and no prescription (Rx) needed or medicine. The patient had no prior vaccination. On 17Mar2021 at 18:30, the patient experienced bloody nose/HBP, which were considered as important medical events. The patient also had bloody nose/HBP on 21Mar2021 at 18:30 and on 28Mar2021 at 19:00. The adverse events (AE) required the patient to visit the emergency room and then to the physician office. The patient underwent lab tests and procedures, which included COVID-19 test: negative on 12Feb2021. Therapeutic measures were taken as a result of HBP, which included Rx for high blood pressure including amlodipine 10 mg. The patient did not receive any treatment for bloody nose. The patient was advised to stop Rx if electrocardiogram (EKG) was abnormal. The patient recovered from the events on an unspecified date in 2021.
COVID Rapid Test and COVID-19 PCR test positive/ symptomatic/ fever/ not feeling well; COVID Rapid Test and COVID-19 PCR test positive/ symptomatic/ fever/ not feeling well; This is a spontaneous report from a Pfizer-sponsored Program Pfizer First Connect. A contactable nurse reported for a male patient (husband) with unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK5730) via IM injection left deltoid on 19Dec2020 at single dose for COVID Prevention. Medical history and concomitant medications were none. The patient did not receive any other vaccines on the same day as the COVID vaccine. The patient was a healthcare professional. The vaccine was not specifically prescribed to the patient, but rather was given to him via his workplace policy, although it was not mandatory. The patient received 1st dose on 19Dec2020, and he had exposure to the virus at work, and on 01Jan2021 he woke up with a fever and was not feeling well and tested positive for COVID-19. Currently he is still symptomatic. The reporter is inquiring about how to follow up with the second dose for the patient, as the patient is due for his second dose on 09Jan2021. It was reported that it had mostly been a low grade fever. The patient had both COVID Rapid Test and COVID-19 PCR test performed on 01Jan2021, and both were positive. The outcome of event was unknown.  The reporter was unsure of seriousness for the patient's positive COVID tests, so far it had not been terrible, but he was still symptomatic, so it was hard to say seriousness at this time. Relatedness of vaccine to event fever and positive COVID test both rapid and PCR from the reporter was unrelated.; Sender's Comments: Based on the information currently available, a lack of efficacy with the suspected vaccine BNT162B2 cannot be completely excluded. However, it is unlikely that the patient would have fully developed immunity due to the very short time lag between the first vaccine dose and the event onset.
This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. The patient's medical history, drug reactions/allergies and concurrent conditions were not reported.  In November 2016 (reported as 15-NOV-2016 or 16-NOV-2016), the patient was vaccinated with a dose of ZOSTAVAX (Lot #, expiration date, strenght, dose, frequency and route were not reported) for prophylaxis. Other suspect therapies included M-M-R II which was administered on 17-NOV-2016, (Lot #, expiration date, strenght, dose, frequency and route were not reported) for prophylaxis and many other unspecified vaccines were administered for citizenship purposes in the last 48 to 72 hours. Additionally, it was reported that the patient's varicella vaccination history was unknown. No adverse events were reported. No product Quality Complaint (PQC) was involved. Additional information is not expected, since the physician wished not to be contacted.
Information has been received from a medical assistant concerning a 55 yr old male who on an unspecified date was vaccinated IM with pneumococcal 23v polysaccharide vaccine. It was unk if the pt received the vaccination in the leg. On an unspecified date, the pt developed a red, painful, local unspecified date, the pt developed a red, painful, local reaction after receiving pneumococcal 23v polysaccharide vaccine. The pt sought unspecified medical attention. It was reported that as a result of these reactions the office was going to give all future pneumococcal 23v polysaccharide vaccines SC. At the time of this report, the pt had recovered from the events (date unk). Additional information is not expected.
Rash on bilateral forearms that started on 9/22/2021 and has continued to spread since then to the bilateral upper arms, neck, and ears. Using hydrocortisone cream three times a day and Allegra daily with no improvement. Pharmacist was informed prior to vaccine that I had a generalized rash on bilateral upper extremities with the  first COVID vaccine (administered 8/4/2021) as well.
About an hour and 15 min. after typoid shot vaccine given, patient reacted strongly, with chills, high fever, pain in his legs, esp. knees. He was shaking quite strongly. This lasted for about 20 minutes. We were on our way to the emergency room when all his symptoms slowly disappeared, or lessened. It is now 3 hours later, and he is listless, and not eating, but it appears his fever is gone, and he is no longer so cold.
15 month old received Comvax and developed pharyngitis and fever of 103 degrees the following day. Negative strep tet and unclear is coincidental URI/pharyngitis vs. immunizatin rex.
pt recv vax;in aug1993 pt had an indented, reddened & bruised area at inject site that was dx as subcutaneous necrosis of the underlying tissue; no pain or dec motion in arm;to MD
tested positive for covid; This is a spontaneous report from a contactable consumer (patient). A 68-years-old female patient with unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date: unknown), via an unspecified route of administration, on Monday, as a single dose for COVID-19 immunisation. Patient's medical history and concomitant medications were not reported. On an unknown date, unspecified Monday, the patient tested positive. The patient asking if she should still receive the second vaccine. The patient underwent lab tests and procedures which included COIVD-19 test which was positive. Outcome of the event was unknown  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Information has been received from a health professional concerning an 11 year old female with no allergies who on 25-JUN-2007 was vaccinated SC on right arm with a second dose of varicella virus vaccine live (Oka/Merck) (Lot # 657403/0715U). Concomitant therapy included IM sixth dose on left arm of Adacel (Lot # C269CAA). At the time of vaccination there was no illness. It was reported that the patient developed redness, swelling and pain after vaccination. No medical attention was sought. At the time of report the patient had recovered. Additional information has been requested. This is one of several reports from the same source.
patient came into the clinic to receive his COVID vaccine. patient received 2 doses of Pfizer at  pharmacy. data inputed  on 4/17/21. made appt for Moderna by appt ctr on 4/23/21. discovered the error when patient tried to make 2nd appt.
Two weeks after receiving my 2nd shot I started to have some tingling and pins/needle feeling in my legs that has since spread throughout my entire body, my skin is very sensitive and feels tight. The only thing I changed was that I got the shot so I believe that this has caused some adverse reaction to happen in my body that seems to be not going away
Tested positive for COVID; Patient felt culled and revise after shot; This is a spontaneous report from a non-contactable consumer. This report was received via a sales representative. A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 30Jan2021 at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 02Feb2021. The patient experienced tested positive for COVID (sars-cov-2 test positive), patient felt culled and revise after shot (feeling abnormal) (non-serious) on 02Feb2021. The outcome of events were unknown.   No follow up attempts are possible. Information about Lot and batch number cannot be obtained.
A day after the vaccine my mouth felt tender inside and slight sore throat, tender underneath my jaw, each day got worst, the teeth hurt, also, I went to the dentist yesterday and he said it's not the teeth, he sent me to a specialist, it looks kind of infection, I have an appointment for tomorrow.
1) Chest heaviness / tightness, 24 hours post vaccination. Rx in Emergency Room/ NTG X 2/ 02. Admitted for cardiac work-up. Hospitalized 1 day (overnight). 2) Itching, bruise, warmth at injection site within 24 hours.
Patient developed swelling/mass on right thigh - seen in clinic 10/24/07, no treatment given.  Swelling resolved.